https://www.selleckchem.com/pr....oducts/NVP-TAE684.ht
3%, p0.001). pooled prevalence of migraine in different continents were significantly different (p0.001). The pooled prevalence was 24% in Asian countries, 43% in American countries, 25% in European countries and 43% in African countries. The results of this systematic review shows that the prevalence of migraine in MS patients is 31% while the prevalence differs significantly among residents of different continents. The results of this systematic review shows that the prevalence of migraine in MS patients is 31% while the pr